AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
69.85
-0.22 (-0.31%)
At close: Jun 27, 2025, 4:00 PM
70.45
+0.60 (0.86%)
After-hours: Jun 27, 2025, 7:59 PM EDT
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
$583,054
Profits / Employee
$82,418
Market Cap
220.36B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AZN News
- 20 hours ago - Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium - Accesswire
- 4 days ago - AstraZeneca's Datroway Approved to Treat Non-Small Cell Lung Cancer in U.S. - WSJ
- 4 days ago - US approves AstraZeneca, Daiichi's treatment for lung cancer - Reuters
- 14 days ago - 5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List - Seeking Alpha
- 15 days ago - AstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 Billion - WSJ
- 15 days ago - AstraZeneca agrees to research deal worth up to $5.22 billion with CSPC - Reuters
- 24 days ago - Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO - CNBC
- 27 days ago - 'Transformational' new drug could stop breast cancer tumours before they grow, trial finds - Skynews